NEWS / IR
-
2022. 03. 23IRPublic Announcement of Financial Results of the 7th Fiscal Year and Capital Reduction
-
2022. 03. 23IRCellusion and Toyo Seikan Group Holdings enter Capital and Business Alliance of CLS001 for Corneal Endothelial Cell Regenerative Therapy
-
2022. 03. 01IRCellusion established the Board of Corporate Auditors
-
2022. 03. 01IRAnnouncement of Changes to Officer Personnel
-
2022. 01. 18MEDIACellusion’s Series B fundraising was introduced in BioWorld
-
2022. 01. 07NEWSCellusion obtained JHVS Venture Award 2021
-
2022. 01. 07IRCellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy
-
2022. 01. 07IRCellusion and Toho Holdings enter Capital and Business Alliance of CLS001 for Corneal Endothelial Cell Regenerative Therapy
-
2022. 01. 07IRCellusion welcomes Dr. Naonori Kurokawa and Dr. Hiroaki Kobayashi to the Management Team
-
2021. 11. 16NEWSCellusion obtained 1st prize of JHVS2021 Global Pitch
